A previous work by our group demonstrated that SFAS’s anti-CHF effects involve mitigating inflammation, suppressing renin-angiotensin-aldosterone system (RAAS) overactivity, modulating adrenergic receptor expression, and improving myocardial energy metabolism (Yu, 2020). The gene discussed is REN; the disease is congestive heart failure.